AzurRx BioPharma has enrolled the first three patients in its Phase 2b trial investigating MS1819 as a treatment…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
Cystic Fibrosis Ireland has set aside up to €120,000 ($141,150) to provide personal protective equipment (PPE) to people with…
The government of Northern Ireland reached a deal with Vertex Pharmaceuticals to make Kaftrio (ivacaftor/tezacaftor/elexacaftor)…
A new technology could enable faster and more accurate cystic fibrosis (CF) diagnoses by non-invasively tracking the movement of…
The EveryLife Foundation for Rare Diseases has launched a nationwide National Burden of Rare Disease Survey to measure…
Cystic fibrosis (CF) patients who monitored their lung function at home using NuvoAir‘s handheld spirometer and smartphone app were…
Anxiety related to fears of COVID-19 infection was higher among mothers of children with cystic fibrosis (CF) than those of…
The Alexion Charitable Foundation has awarded $1.1 million in grants to programs that support those with rare diseases during…
Thousands of people in England with cystic fibrosis (CF) soon will be equipped with digital home spirometry kits. This…
The Black Women’s Health Imperative (BWHI) recently created a Rare Disease Diversity Coalition focused on reducing racial disparities in…